drugset / Trial / NCT07374406
To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, single dose, 2x2 crossover study to evaluate the safety and pharmacokinetic characteristics after administration of Epaminurad in healthy adult volunteers under fasting conditions
Timeline
- Start
- 2026-02-02
- Primary completion
- 2026-02-19
- Completion
- 2026-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epaminurad | Small molecule | 9 mg | Oral |
Indications
No indication recorded.